Provenge Injection
Product Images NDC 30237-8900

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Provenge (NDC 30237-8900). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dendreon Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pro02 0012 01)

This is a graph showing the percent survival rate over time for two groups, PROVENGE and Placebo, with sample sizes of 341 and 171 respectively. The survival rates are shown at 20%, 40%, 60%, and 80%. The x-axis displays time in months from randomization.*

FDA Label Image

Package Label 2 (Pro02 0012 04)

This is a description of a Shulucsl T 250ml Lk. The product needs to be stored in a refrigerated place between 2 and 8°C and MUST not be frozen. The expiration date for this product is 01-JUL-2008. The product has not been evaluated for infectious substances. Additional information, such as ingredients or purpose, is not available.*

FDA Label Image

Principal Display Panel – Carton Label (Pro02 0015 02)

Sipuleucel-T (marketed as PROVENGE by StiberiaGal) is a drug that contains a minimum of 50 million autologous CD54+ cells suspended in Lactated Ringer's Injection, USP and activated with PAP-GM-CSF. The drug is manufactured and distributed by Dendreon Pharmaceuticals LLC without any preservatives. PROVENGE is meant for infusion and package insert should be consulted for dosage and administration details. The U.S. license number for PROVENGE is 1749.*

FDA Label Image

Principal Display Panel – Bag Label (Pro02 0015 03)

This is a description of a medical product called PROVENGE, manufactured by Dendreon Pharmaceuticals LLC. The contents contain at least 50 million autologous CD54 cells activated with PAP-GM-CSF and suspended in Lactated Ringer's Injection. The product has no preservatives and must be gently mixed and re-suspended before use. The company's contact information is provided, including a phone number for prescription information and administration instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.